Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Kentucky
Dana-Farber Cancer Institute
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
University of Chicago
University of Alabama at Birmingham
Case Comprehensive Cancer Center
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
EpicentRx, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boston Scientific Corporation
University of Texas Southwestern Medical Center
Hunan Cancer Hospital
University Health Network, Toronto
Sun Yat-sen University
University of Texas Southwestern Medical Center
West China Hospital
University of Chicago
Daiichi Sankyo
Amgen
Russian Academy of Medical Sciences
Emory University
Amgen
HealthCare Global Enterprise Ltd.
Memorial Sloan Kettering Cancer Center
Biotech Pharmaceutical Co., Ltd.
AstraZeneca
Dana-Farber Cancer Institute